Travoprost API

Name	Travoprost
Chinese name	曲伏前列素
Cas Number	157283-68-6
Source	Europe
Qualifications	USDMF/-/-/-/-

Travoprost is a prostaglandin analogue, developed by Alcon Corporation of the United States. It was listed in the United States in 2001 and has been marketed in dozens of countries around the world. It is currently one of the first-line drugs for the treatment of glaucoma. Prostaglandin analogs can increase the excretion of aqueous humor, thereby reducing intraocular pressure. Clinical trials have shown that the improvement of vision, astigmatism before and after treatment, and the improvement of intraocular pressure at different times after treatment are significantly better than that of Timolol maleate; the incidence of adverse reactions is significantly lower than that of Timol maleate. Morol. At present, the approved prostaglandin analogs in China are latanoprost, tafluprost, travoprost, and bemeprost. Among them, only latanoprost has domestic preparations, and the others are imported products. Alcon data shows that its exclusive variety of travoprost eye drops has a strong growth momentum. In 2014, it reached almost 50% of the total amount of prostaglandin analogs. In 2018, global sales were 3.287 billion yuan.

Hot Tags: travoprost api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Pregabalin API, Adapalene API, Fulvestrant API, Pazopanib Hydrochloride Pazopanib API, Edoxaban API, Celecoxib API

• Previous: Topiramate API
• Next: Ezetimibe API